KIFC1 is a potential target to prevent treatment resistance in prostate cancer

被引：0
|
作者：
Torga, Gonzalo [1 ]
Lin, Ke-Chih [2 ]
Serer, Bernat Navarro [1 ]
Nguyen, Cathleen [1 ]
Austin, Robert H. [2 ]
Pienta, Kenneth J. [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Princeton Univ, Princeton, NJ 08544 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-1977
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1977
引用
收藏
页数：2
相关论文
共 50 条
  • [1] KIFC1: a promising chemotherapy target for cancer treatment?
    Xiao, Yu-Xi
    Yang, Wan-Xi
    [J]. ONCOTARGET, 2016, 7 (30) : 48656 - 48670
  • [2] KIFC1 is a novel potential therapeutic target for breast cancer
    Li, Yonghe
    Lu, Wenyan
    Chen, Dongquan
    Boohaker, Rebecca J.
    Zhai, Ling
    Padmalayam, Indira
    Wennerberg, Krister
    Xu, Bo
    Zhang, Wei
    [J]. CANCER BIOLOGY & THERAPY, 2015, 16 (09) : 1316 - 1322
  • [3] KIFC1 is involved in the regulation of resistance against docetaxel in prostate cancer
    Sekino, Yohei
    Koike, Yuki
    Shigematsu, Yoshinori
    Hattori, Takuya
    Sakamoto, Naoya
    Shiota, Masaki
    Sentani, Kazuhiro
    Oue, Naohide
    Teishima, Jun
    Matsubara, Akio
    Yasui, Wataru
    [J]. CANCER SCIENCE, 2018, 109 : 1024 - 1024
  • [4] KIFC1 induces resistance to docetaxel and is associated with survival of patients with prostate cancer
    Sekino, Yohei
    Oue, Naohide
    Shigematsu, Yoshinori
    Ishikawa, Akira
    Sakamoto, Naoya
    Sentani, Kazuhiro
    Teishima, Jun
    Matsubara, Akio
    Yasui, Wataru
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (01) : 31.e13 - 31.e20
  • [5] High KIFC1 expression is associated with poor prognosis in prostate cancer
    Laurie G. Kostecka
    Athen Olseen
    KiChang Kang
    Gonzalo Torga
    Kenneth J. Pienta
    Sarah R. Amend
    [J]. Medical Oncology, 2021, 38
  • [6] KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma
    Fu, Xiaowei
    Zhu, Yaqiong
    Zheng, Bingbing
    Zou, Yeqing
    Wang, Chao
    Wu, Peng
    Wang, Jun
    Chen, Haimin
    Du, Pengcheng
    Liang, Bo
    Fang, Lu
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (06) : 1912 - 1922
  • [7] High KIFC1 expression is associated with poor prognosis in prostate cancer
    Kostecka, Laurie G.
    Olseen, Athen
    Kang, KiChang
    Torga, Gonzalo
    Pienta, Kenneth J.
    Amend, Sarah R.
    [J]. MEDICAL ONCOLOGY, 2021, 38 (05)
  • [8] KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer
    Sekino, Yohei
    Oue, Naohide
    Koike, Yuki
    Shigematsu, Yoshinori
    Sakamoto, Naoya
    Sentani, Kazuhiro
    Teishima, Jun
    Shiota, Masaki
    Matsubara, Akio
    Yasui, Wataru
    [J]. JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02):
  • [9] KIFC1 as a novel therapeutic target for p53 mutant colorectal cancer
    Mittal, Karuna
    Wei, Guanhao
    Kaur, Jaspreet
    Melton, Brian D.
    Choi, Da H.
    Reid, Michelle
    Rida, Padmashree
    Aneja, Ritu
    [J]. MODERN PATHOLOGY, 2018, 31 : 289 - 289
  • [10] KIFC1 as a novel therapeutic target for p53 mutant colorectal cancer
    Mittal, Karuna
    Wei, Guanhao
    Kaur, Jaspreet
    Melton, Brian D.
    Choi, Da H.
    Reid, Michelle
    Rida, Padmashree
    Aneja, Ritu
    [J]. LABORATORY INVESTIGATION, 2018, 98 : 289 - 289
12345